Syschem (India) has informed that pursuant to Regulation 29 of SEBI Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the company will be held on 12th August, 2017 at 4.00 P.M. at the Corporate Office of the Company to consider and take on record the Unaudited Financial Results of the Company for the quarter ended 30th June, 2017. Further, in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with Company’s Code of Conduct for prohibition of insider trading, the trading window for dealing in the securities of the Company would remain closed from 5th August, 2017 to 14th August, 2017 for the directors/officers/designated persons of the Company.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: